Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.18
-0.3800-0.54%
Volume:238.51K
Turnover:16.94M
Market Cap:5.86B
PE:-115.05
High:72.68
Open:71.15
Low:69.85
Close:70.56
52wk High:90.87
52wk Low:49.38
Shares:83.46M
Float Shares:77.19M
Volume Ratio:1.16
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.42
PE(LYR):9.02

Loading ...

PTC Therapeutics CEO Makes Notable Move With Latest Stock Sale

TIPRANKS
·
Apr 24

Tectonic Therapeutic appoints Jessica Chutter to board of directors

Reuters
·
Apr 24

PTC Therapeutics schedules quarterly results webcast conference call

Reuters
·
Apr 22

PTC Therapeutics announces annual shareholder meeting notice

Reuters
·
Apr 21

BRIEF-Ptc Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 18

PTC Therapeutics grants new hire 1,155 stock options, 925 RSUs under Nasdaq rule

Reuters
·
Apr 18

Analysts’ Top Healthcare Picks: PTC Therapeutics (PTCT), PDS Biotechnology (PDSB)

TIPRANKS
·
Apr 16

PTC Therapeutics (PTCT) Receives a Buy from Raymond James

TIPRANKS
·
Apr 13

Is It Time To Reassess PTC Therapeutics (PTCT) After Its Strong One Year Rally?

Simply Wall St.
·
Apr 13

PTC Therapeutics initiated with an Outperform at Raymond James

TIPRANKS
·
Apr 10

Barclays Remains a Buy on PTC Therapeutics (PTCT)

TIPRANKS
·
Apr 09

PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes of USD 101,111 common shares

Reuters
·
Apr 09

PTC Therapeutics price target lowered to $81 from $82 at RBC Capital

TIPRANKS
·
Apr 07

RBC Adjusts Price Target on PTC Therapeutics to $81 From $82, Maintains Sector Perform Rating

MT Newswires Live
·
Apr 07

Top PTC Therapeutics Executive Makes Notable Insider Stock Move

TIPRANKS
·
Apr 07

PTC Therapeutics Chief Technical Ops Officer Neil Gregory Almstead sells USD 3.6 million stock

Reuters
·
Apr 04

PTC Therapeutics Cut to Hold From Buy by Jefferies

Dow Jones
·
Mar 31

PTC Therapeutics assumed at Hold from Buy at Jefferies

TIPRANKS
·
Mar 30

A Look At PTC Therapeutics (PTCT) Valuation As Shares Reflect Mixed Recent Returns

Simply Wall St.
·
Mar 27

PTC Therapeutics files initial beneficial ownership statement; Director Jessica Caroline Chutter reports no securities beneficially owned

Reuters
·
Mar 27